Development of QSAR machine learning-based models to forecast the effect of substances on malignant melanoma cells
暂无分享,去创建一个
Robert Ancuceanu | Mihaela Dinu | Iana Neaga | Fekete Gyula Laszlo | Daniel Boda | D. Boda | M. Dinu | Robert Ancuceanu | Iana Neaga | F. Laszlo
[1] J. Dearden. The Use of Topological Indices in QSAR and QSPR Modeling , 2017 .
[2] J L Sebaugh,et al. Guidelines for accurate EC50/IC50 estimation , 2011, Pharmaceutical statistics.
[3] E. Souto,et al. Repurposing itraconazole to the benefit of skin cancer treatment: A combined azole-DDAB nanoencapsulation strategy. , 2018, Colloids and surfaces. B, Biointerfaces.
[4] Sheng-Ping L. Hwang,et al. A novel stilbene‐like compound that inhibits melanoma growth by regulating melanocyte differentiation and proliferation , 2017, Toxicology and applied pharmacology.
[5] Saloni,et al. Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer , 2017, Drug design, development and therapy.
[6] Swagatam Das,et al. Near-Bayesian Support Vector Machines for imbalanced data classification with equal or unequal misclassification costs , 2015, Neural Networks.
[7] S. Loesgen,et al. The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells , 2017, The Journal of Biological Chemistry.
[8] Ai-qin Niu,et al. Prediction of selective estrogen receptor beta agonist using open data and machine learning approach , 2016, Drug design, development and therapy.
[9] Supratik Kar,et al. On a simple approach for determining applicability domain of QSAR models , 2015 .
[10] Yuanfang Guan,et al. Accurate prediction of personalized olfactory perception from large-scale chemoinformatic features , 2017, GigaScience.
[11] C. Ferrone,et al. Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives. , 2017, Anti-Cancer Agents in Medicinal Chemistry.
[12] Alexander Golbraikh,et al. Application of Quantitative Structure–Activity Relationship Models of 5-HT1A Receptor Binding to Virtual Screening Identifies Novel and Potent 5-HT1A Ligands , 2014, J. Chem. Inf. Model..
[13] Miklos Feher,et al. Global or Local QSAR: Is There a Way Out? , 2009 .
[14] Jie Li,et al. In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models , 2018, ChemMedChem.
[15] Y. S. Prabhakar,et al. QSAR of 2-(4-methylsulphonylphenyl)pyrimidine derivatives as cyclooxygenase-2 inhibitors: simple structural fragments as potential modulators of activity , 2012, Journal of enzyme inhibition and medicinal chemistry.
[16] J. Dimmock,et al. Comparative QSAR Analysis of 3,5-bis (Arylidene)-4-Piperidone Derivatives: the Development of Predictive Cytotoxicity Models , 2016, Iranian journal of pharmaceutical research : IJPR.
[17] N. Omar,et al. Synthesis and In Vitro Antiproliferative Activity of New 1-Phenyl-3-(4-(pyridin-3-yl)phenyl)urea Scaffold-Based Compounds , 2018, Molecules.
[18] A. Fassihi,et al. QSAR Study of p56lck Protein Tyrosine Kinase Inhibitory Activity of Flavonoid Derivatives Using MLR and GA-PLS , 2008, International journal of molecular sciences.
[19] Eslam Pourbasheer,et al. QSAR Study of 17β-HSD3 Inhibitors by Genetic Algorithm-Support Vector Machine as a Target Receptor for the Treatment of Prostate Cancer , 2017, Iranian journal of pharmaceutical research : IJPR.
[20] A. Zarghi,et al. QSAR Modeling of COX -2 Inhibitory Activity of Some Dihydropyridine and Hydroquinoline Derivatives Using Multiple Linear Regression (MLR) Method , 2017, Iranian journal of pharmaceutical research : IJPR.
[21] Qihong Huang,et al. The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer , 2016, Oncotarget.
[22] Qi Wang,et al. In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers , 2018, J. Chem. Inf. Model..
[23] Feixiong Cheng,et al. In silico Prediction of Chemical Ames Mutagenicity , 2012, J. Chem. Inf. Model..
[24] Robert P. Sheridan,et al. Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..
[25] Andrej Sali,et al. Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. , 2013, Journal of medicinal chemistry.
[26] C. Nantasenamat,et al. Discovery of novel 1,2,3-triazole derivatives as anticancer agents using QSAR and in silico structural modification , 2015, SpringerPlus.
[27] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[28] Saroj Verma,et al. Topological and physicochemical characteristics of 1,2,3,4-Tetrahydroacridin- 9(10H)-ones and their antimalarial profiles: a composite insight to the structure-activity relation. , 2013, Current computer-aided drug design.
[29] A. Tsatsakis,et al. The Cytotoxic Effects of Betulin-Conjugated Gold Nanoparticles as Stable Formulations in Normal and Melanoma Cells , 2018, Front. Pharmacol..
[30] Peter Dalgaard,et al. R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .
[31] A. Sakhteman,et al. A Comparative QSAR Analysis, Molecular Docking and PLIF Studies of Some N-arylphenyl-2, 2-Dichloroacetamide Analogues as Anticancer Agents , 2017, Iranian journal of pharmaceutical research : IJPR.
[32] Isidro Cortes-Ciriano,et al. Comparing the Influence of Simulated Experimental Errors on 12 Machine Learning Algorithms in Bioactivity Modeling Using 12 Diverse Data Sets , 2015, J. Chem. Inf. Model..
[33] Roberto Todeschini,et al. A QSTR-Based Expert System to Predict Sweetness of Molecules , 2017, Front. Chem..
[34] H. Zeng,et al. Predictive QSAR Models for the Toxicity of Disinfection Byproducts , 2017, Molecules.
[35] Bernd Bischl,et al. mlr: Machine Learning in R , 2016, J. Mach. Learn. Res..
[36] Sk Abdul Amin,et al. Monte Carlo based modelling approach for designing and predicting cytotoxicity of 2-phenylindole derivatives against breast cancer cell line MCF7. , 2018, Toxicology in vitro : an international journal published in association with BIBRA.
[37] N. Andreatos,et al. Targeting Histone Deacetylases in Malignant Melanoma: A Future Therapeutic Agent or Just Great Expectations? , 2017, Anticancer research.
[38] Alois Knoll,et al. Gradient boosting machines, a tutorial , 2013, Front. Neurorobot..
[39] Q. Wang,et al. Docking Analysis and Multidimensional Hybrid QSAR Model of 1,4-Benzodiazepine-2,5-Diones as HDM2 Antagonists , 2012, Iranian journal of pharmaceutical research : IJPR.
[40] Roberto Todeschini,et al. Defining a novel k-nearest neighbours approach to assess the applicability domain of a QSAR model for reliable predictions , 2013, Journal of Cheminformatics.
[41] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[42] M. Bouachrine,et al. QSAR study and rustic ligand-based virtual screening in a search for aminooxadiazole derivatives as PIM1 inhibitors , 2018, Chemistry Central Journal.
[43] R. Karbakhsh,et al. Application of different chemometric tools in QSAR study of azolo-adamantanes against influenza A virus , 2011, Research in pharmaceutical sciences.
[44] Vinicius M. Alves,et al. QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities , 2018, Front. Pharmacol..
[45] Mohammed K. Abdelhameid,et al. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7. , 2018, European journal of medicinal chemistry.
[46] S. Gibbons,et al. Differential modulation of Bax/Bcl-2 ratio and onset of caspase-3/7 activation induced by derivatives of Justicidin B in human melanoma cells A375 , 2017, Oncotarget.
[47] R. Means,et al. p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis. , 2017, The Journal of investigative dermatology.
[48] Artem Cherkasov,et al. SimBoost: a read-across approach for predicting drug–target binding affinities using gradient boosting machines , 2017, Journal of Cheminformatics.
[49] A. Vulpetti,et al. Comparability of Mixed IC50 Data – A Statistical Analysis , 2013, PloS one.
[50] A. Mohanapriya,et al. Comparative QSAR analysis of cyclo-oxygenase2 inhibiting drugs , 2012, Bioinformation.
[51] J. Gower. A General Coefficient of Similarity and Some of Its Properties , 1971 .
[52] Anna Kryshchyshyn,et al. Development of Predictive QSAR Models of 4‐Thiazolidinones Antitrypanosomal Activity Using Modern Machine Learning Algorithms , 2018, Molecular informatics.
[53] Hybrid Docking-QSAR Studies of 1, 4-dihydropyridine-3, 5-Dicarboxamides as Potential Antitubercular Agents. , 2017, Current computer-aided drug design.
[54] G. Box. Robustness in the Strategy of Scientific Model Building. , 1979 .
[55] Roberto Todeschini,et al. Towards Global QSAR Model Building for Acute Toxicity: Munro Database Case Study , 2014, International journal of molecular sciences.
[56] Roberto Todeschini,et al. In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9 , 2016, International journal of molecular sciences.
[57] Kurt Hornik,et al. Misc Functions of the Department of Statistics (e1071), TU Wien , 2014 .
[58] S. Haryana,et al. Biological activity, quantitative structure–activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs , 2018, Drug design, development and therapy.